AI Governance for Private GP and GP-Led Clinics

Why private GP clinics are ELSA AI’s primary audience

Private GP clinics sit at the intersection of four pressures.

1. 1. CQC-regulated clinical activity

   GP services are assessed through CQC’s regulatory framework, including Safe and Well-led evidence expectations. Where AI affects clinical records, care workflows, data processing or human oversight, the clinic needs a documented position.

2. 2. GP-specific AI inspection signals

   CQC’s GP Mythbuster 109 is GP-specific guidance on AI in GP services. It references risk assessment, responsible roles, clinical governance, human oversight, monitoring and evaluation of AI outputs. It is not a substitute for the clinic’s own legal, regulatory or clinical safety review, but it is a clear governance-standard signal for GP providers.

3. 3. High-volume special category health data

   GP consultations generate sensitive clinical information at volume. AI tools that process consultation audio, notes, correspondence, images, summaries or patient identifiers need DPIA screening. In many cases, a DPIA is likely required or strongly indicated, with DPO/legal review needed where processing is likely high risk.

4. 4. Insurer, MDO and PMI scrutiny

   AI use may become relevant to insurer, PMI or MDO questions, especially where tools affect clinical documentation, patient communication, consultation recording, diagnosis, triage or professional accountability. The MDU has warned that using AI outside organisational approval and governance may carry personal risks, and that doctors remain responsible for accurate clinical records, including notes transcribed by AI systems.

The typical governance position we find

In private GP and GP-led clinics, the recurring pattern is usually an evidence gap rather than a single catastrophic failure.

Common findings include:

• AI is in use, but there is no single inventory of tools, users, purposes or patient-data exposure.
• There is no AI-specific policy distinguishing approved, conditional and prohibited use.
• Ambient scribe or transcription use has started before the DPIA workpack is ready for DPO review.
• Vendor evidence is incomplete or scattered across email, procurement files and individual clinicians.
• Staff have not received a clear written position on ChatGPT, Copilot, transcription tools or personal-device AI.
• There is no documented board or partnership view of AI risk.
• Incident reporting does not explicitly cover AI-related issues such as hallucinated notes, transcription errors or unintended disclosure.

None of this means the clinic is “non-compliant.” It means there is an evidence gap. That gap becomes urgent when a DPO, insurer, MDO, CQC inspector, board member or patient asks how AI use is controlled.

Common triggers for engaging ELSA AI

• CQC inspection scheduled or anticipated.
• Insurer or PMI renewal questionnaire including AI questions.
• DPO requesting evidence on AI processing of patient data.
• Ambient scribe rollout under consideration, in pilot or already live.
• MDO query following an incident, complaint or routine review.
• Board, partnership or investor AI review.
• Staff, patient or referrer concern about AI use.
• Microsoft Copilot, ChatGPT or transcription tools appearing in workflows without a documented policy.

Fee and timeline

Fixed fee: £4,500–£6,500 + VAT
Delivered within 4 working days from completed intake.

No platform subscription. No retainer required to start.

For clinics that want to convert the Diagnostic into a board-approved governance baseline, the Clinical AI Safe Usage Launchpad™ follows over 4–6 weeks.

For clinics that want their governance evidence kept current as tools, staff use, vendor terms and regulatory expectations change, the AI Exposure Sentinel™ retainer is available from £950 per month.

Founder-delivered

Engagements are led by Faisal Ali, CISM, CRISC — Founder and Principal Consultant of ELSA AI — with more than two decades of experience in cybersecurity, information risk and AI governance across regulated environments.

Senior-led. No junior delegation. No template-and-invoice model.